Montegrande, Marjury .
HRN: 23-25-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/22/2025
CEFUROXIME 1.5GM (VIAL)
04/22/2025
04/22/2025
IV
500mg
Q8
SP PLTCS
Rejected
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Non-compliant To Guidelines